Asmarats L., Li C.-H., Millán X., Menduiña I., Fernández-Peregrina E., Gutiérrez-Alonso L., Torres M., Serra A., Arzamendi D.. Aortic Sinus Contrast Retention During TAVR: A Warning Sign Preceding a Potential Thrombotic Complication. JACC. Case reports. 2022; 4(11)DOI:10.1016/j.jaccas.2022.03.031. PMID:. IF:(Q/D).

Li, CHP, Asmarats, L, Maestre, ML, Fernandez, E, Serra, A, Arzamendi, D. New PASCAL Ace implant system in complex percutaneous mitral valve repair. REC, interventional cardiology. 2022; 4(1)DOI:10.24875/RECICE.M21000201. PMID:. IF:(Q/D).

Ruiz-López A., Li C.-H.P., Valdovinos P., Rodríguez Á., Bonet A., Tauron M., Ligero C., Millan X., Alegret J.M., Viladés D., Arzamendi D.. Hemolytic Anemia After Surgical Mitral Valve Repair Treated With Transcatheter Edge-to-Edge Device. JACC. Case reports. 2022; 4(12)DOI:10.1016/j.jaccas.2022.03.021. PMID:. IF:(Q/D).

Krolewiecki A., Enbiale W., Gandasegui J., van Lieshout L., Kepha S., Messa Junior A., Bengtson M., Gelaye W., Escola V., Martinez-Valladares M., Cambra-Pellejà M., Algorta J., Martí-Soler H., Fleitas P., Ballester M.R., Doyle S.R., Williams N.A., Legarda A., Mandomando I., Mwandawiro C., Muñoz J.. An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol. Gates Open Research. 2022; 6DOI:10.12688/gatesopenres.13615.1. PMID:. IF:(Q/D).